Final height and endocrine function in thalassaemia intermedia

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 965-971

  De Sanctis, V ^a   Tangerini, A ^a   Testa, M R ^a   Lauriola, A L ^a   Gamberini, M R ^a   Cavallini, A R ^a   Rigolin, F ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Endocrinopathies; Iron overload; Thalassaemia intermedia

Indexed keywords

FERRITIN; GONADORELIN; HEMOGLOBIN; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AMENORRHEA; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; DELAYED PUBERTY; ENDOCRINE FUNCTION; EUTHYROID SICK SYNDROME; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPOGONADISM; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; MALE; SECONDARY AMENORRHEA; THALASSEMIA MAJOR; THALASSEMIA MINOR;

ADOLESCENT; ADULT; AMENORRHEA; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; CHELATING AGENTS; ENDOCRINE GLANDS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGONADISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; PUBERTY, DELAYED;

EID: 0032429344     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Bannermann RM, Keush G, Kreimer-Birnbaum M, Vance VK, Vaughan S. Thalassaemia intermedia with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Am J Med 1967; 42: 476-486.
2. Tanner JM. Growth at Adolescence. Oxford: Blackwell Scientific Publications, 1986.
3. Dillon RS, Mawr B. Importance of the hematocrit in interpretation of blood sugar. Diabetes 1965; 14: 672-675.
4. Editorial. Impaired glucose tolerance and diabetes -WHO criteria. BMJ 1980; 281: 1512.
5. Vullo C, De Sanctis V, Katz M, Wonke B, Hoffbrand AV, Bagni B, Torresani T, Tolis G, Masiero M, Di Palma A, Borgatti L. Endocrine abnormalities in thalassamia. Ann NY Acad Sci 1990; 612: 293-310.
6. De Alarcon PA, Donovan ME, Forbes JB, Landaw SA, Stockman JA. Iron absorption in the thalassaemia syndromes and its inibithion by tea. N Engl J Med 1979; 300: 5-8.
7. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F. Insulin dependent diabetes in thalassaemia. Arch Dis Child 1988; 63: 58.
8. Olivieri N. Iron overload and iron-chelating therapy in thalassaemia intermedia. In: Thalassaemia Intermedia. The Genetic Resource. Arlington, VA: National Center for Education in Maternal and Child Health, 1997; 11: 15-19.
9. Kwan EJ, Lee AC, Li AM, Tam CF, Chian CF, Lau YL, Low LCK. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health 1995; 31: 83-87.
10. De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B. Effects of different treatment regimes on linear growth and final height in ß-thalassaemia major. Clin Endocrinol 1994; 40: 791-798.